根据Cedars Sinai医学中心对98例心肌梗塞病人快速输注大剂量链激酶的治疗结果,认为可引起严重的和可能有危险的低血压,特别是对那些在血液动力学方面已有损害的病人。在输注链激酶期间,病人的收缩压平均下降35毫米汞柱,降低最多者为82毫米汞柱,而舒张压则平均下降20毫米汞柱。低血压平均可在9分钟后消失,但有4例左室严重衰竭的病人,尽管给他们静脉输注儿茶酚胺类,但收缩压低于85毫 According to the results of Cedars Sinai Medical Center’s rapid infusion of high-dose streptokinase in 98 patients with myocardial infarction, it is thought to cause serious and potentially dangerous hypotension, especially in patients who have been hemodynamically impaired. During infusion streptokinase, the patient’s systolic blood pressure decreased by an average of 35 mmHg, a decrease of 82 mmHg, and an average decrease of 20 mmHg of diastolic blood pressure. Hypotension averages disappear after 9 minutes, but in 4 patients with severe left ventricular failure, systolic blood pressure was less than 85 milligrams despite intravenous infusion of catecholamines